NCT07393321 2026-02-06
A Phase III Clinical Trial of NTQ1062 in Combination With Fulvestrant for the Treatment of Advanced or Metastatic HR+/HER2- Breast Cancer
Nanjing Chia-tai Tianqing Pharmaceutical
Phase 3 Not yet recruiting
Nanjing Chia-tai Tianqing Pharmaceutical
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Second Affiliated Hospital, School of Medicine, Zhejiang University